Notably, LILRB1 was expressed in 24/26 tested PDX samples representing high-risk B-ALL subtypes including KMT2A-r, BCR-ABL1, BCR-ABL1-like and hypodiploid, with typically moderate but uniform expression levels across cell population (Fig. 3C). Here, LILRB1 is linked to acute lymphoblastic leukemia.